Kyriakos Mikellis, Head of Pfizer in Cyprus and Malta, has been re-elected President of the Cyprus Association of Pharmaceutical Research and Development Companies (KEFEA), for a two-year term.
According to a statement by the KEFEA, Mr. Mikellis, after his re-election, thanked the Board of Directors of the Association "for the renewed confidence in him", noting that "the priorities of the KEFEA for the coming period are to ensure patients' access to the most appropriate treatment for each case".
(CNA)
CNA
Contents of this article including associated images are owned by CNA
Views & opinions expressed are those of the author and/or CNA
Source
